Appearance Of Ovarian Lesions On Ultrasound May Predict Risk For Malignancy

HealthDay (5/27) reported that “the appearance of ovarian lesions on ultrasound may predict the risk for malignancy, according to a” retrospective cohort study. The study – published in Radiology – “included isolated ovarian lesions identified at pelvic ultrasound to examine whether an ultrasound-based classification scheme of classic versus nonclassic appearance can be used to help appropriately triage women […]

Read More

Adding RT To Chemotherapy After Surgery Improves OS In Patients With Stage IV Endometrial Cancer

Cancer Therapy Advisor (5/6, Mistry) reported, “Adding radiotherapy (RT) to chemotherapy after surgery improves overall survival (OS) in patients with stage IV endometrial cancer, according to research.” The data indicated that “the benefit with RT was observed across all histologies except clear cell carcinoma, and the benefit was greatest when chemotherapy was combined with both external […]

Read More

HPV Vaccination May Be Linked To Decrease In Incidence Of Cervical Cancers

HealthDay (3/16) reported, “The recent decrease in the incidence of cervical cancers, particularly in young women, may be associated with human papillomavirus (HPV) vaccination approval, according to a study.” Investigators “found that before vaccination approval, cervical cancer rates in the 20- to 24-year age group were decreasing at 2.29 percent annually; since approval, the rate has […]

Read More

Web-Based Program May Improve Symptom Control For Patients With Recurrent Ovarian Cancer

Cancer Therapy Advisor (3/7, Mistry) reported that “a web-based program called ‘WRITE Symptoms’ can improve symptom control for patients with recurrent ovarian cancer, according to a study” that “enrolled 497 patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer who had 3 or more symptoms.” The study findings published in the Journal of Clinical Oncology revealed […]

Read More

Secondary Cytoreductive Surgery Resulting in Maximal Tumor Resection Improves Overall Survival In Recurrent Ovarian Cancer

MedPage Today  (2/23, Bankhead) reported, “Secondary cytoreductive surgery (SCS) for recurrent ovarian cancer significantly improved overall survival…when surgery achieved maximal tumor resection, a large meta-analysis showed.” According to the results  published in the Journal of Clinical Oncology, “pooled data from 36 studies showed a death rate of 44.2%, which decreased substantially with increasing rates of complete and optimal SCS.” […]

Read More

COVID-19 mRNA Vaccination Is Just As Safe For People With Cancer As It Is For Cancer-Free Individuals

MedPage Today (2/7, Bassett) reported, “COVID-19 mRNA vaccination is just as safe for people with cancer as it is for cancer-free individuals, according to a prospective, single-institution observational study.” Investigators found that “among a cohort of over 1,700 patients, more than two-thirds of whom had a history of cancer, local pain at the injection site was […]

Read More